Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To see whether intravenous acetylcysteine would improve outcome in patients with fulminant hepatic failure after paracetamol overdose. DESIGN: A prospective randomised controlled study. SETTING: The Institute of Liver Studies, King's College Hospital, London. PATIENTS: 50 consecutive patients (21 male) aged 16-60 with fulminant hepatic failure after paracetamol overdose who had not previously received acetylcysteine. INTERVENTIONS: Conventional intensive liver care plus either acetylcysteine (25 patients) in the same dose regimen as used early after a paracetamol overdose, except that the infusion was continued until recovery from encephalopathy or death, or an equivalent volume of 5% dextrose (25 patients). MAIN OUTCOME MEASURES: Survival; incidence of cerebral oedema, renal failure, and hypotension requiring inotropic support; liver function as assessed by prolongation of the prothrombin time; and degree of encephalopathy. RESULTS: The rate of survival was significantly higher in the acetylcysteine treated group than in the controls (48% (12/25 patients) v 20% (5/25); p = 0.037, 95% confidence interval for difference in proportions surviving 3% to 53%). Acetylcysteine treated patients had a lower incidence of cerebral oedema (40% (10/25) v 68% (17/25); p = 0.047, 95% confidence interval for difference in incidence 2% to 54%), and fewer developed hypotension requiring inotropic support (48% (12/25) v 80% (20/25); p = 0.018, 95% confidence interval 7% to 57%). Rates of deterioration and recovery of liver function, however, were similar in the two groups. No adverse reactions to acetylcysteine were seen. CONCLUSIONS: Acetylcysteine is safe and effective in fulminant hepatic failure after paracetamol overdose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Self-citationAruoma, O. I., Halliwell, B., Hoey, B. M., & Butler, J. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90066-x · Cited by 1,772
Prognosis in Acute Organ-System Failure
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Annals of Surgery · doi:10.1097/00000658-198512000-00004 · Cited by 1,225
Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., & Proudfoot, A. T. (1980) · BMJ · doi:10.1136/bmj.280.6206.46-b · Cited by 626
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
Self-citationControlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
O'Grady, J. G., Gimson, A. E. S., O'Brien, C. J., Pucknell, A., Hughes, R. D., & Williams, R. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90011-x · Cited by 538
Self-citationHarrison, P. M., Keays, R., Bray, G. P., Alexander, G. J. M., & Williams, R. (1990) · The Lancet · doi:10.1016/0140-6736(90)91388-q · Cited by 398
Self-citationAcetaminophen Overdose: 662 Cases With Evaluation of Oral Acetylcysteine Treatment
Rumack, B. H. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340030112020 · Cited by 350
The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage
Prescott, L. F., Donovan, J. W., Jarvie, D. R., & Proudfoot, A. T. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00558131 · Cited by 185
Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure.
Harrison, P. M., O'Grady, J. G., Keays, R. T., Alexander, G. J., & Williams, R. (1990) · BMJ · doi:10.1136/bmj.301.6758.964 · Cited by 170
Self-citation
Cited by
AASLD position paper: The management of acute liver failure†
Polson, J., & Lee, W. M. (2005) · Hepatology · doi:10.1002/hep.20703 · Cited by 974
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
Wendon, J., Cordoba, J., Dhawan, A., Larsen, F. S., Manns, M., Nevens, F., Samuel, D., Simpson, K. J., Yaron, I., & Bernardi, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.003 · Cited by 917
Self-citationStravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759
Acute liver failure: Summary of a workshop†
Lee, W. M., Squires, R. H., Nyberg, S. L., Doo, E., & Hoofnagle, J. H. (2008) · Hepatology · doi:10.1002/hep.22177 · Cited by 757
Chiral Toxicology: It's the Same Thing…Only Different
Smith, S. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp097 · Cited by 602
Fulminant hepatic failure: Summary of a workshop
Hoofnagle, J. H., Carithers, R. L., Shapiro, C., & Ascher, N. (1995) · Hepatology · doi:10.1002/hep.1840210137 · Cited by 533
Acetylcysteine for Acetaminophen Poisoning
Heard, K. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0708278 · Cited by 467
Larson, A. M. (2007) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.06.006 · Cited by 451
N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413
Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure
Jalan, R., Damink, S. W., Deutz, N. E., Lee, A., & Hayes, P. C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12440-6 · Cited by 363
Acetaminophen Hepatotoxicity and Acute Liver Failure
Chun, L. J., Tong, M. J., Busuttil, R. W., & Hiatt, J. R. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31818a3854 · Cited by 348
Nematollahi, D., Shayani-Jam, H., Alimoradi, M., & Niroomand, S. (2009) · Electrochimica Acta · doi:10.1016/j.electacta.2009.07.077 · Cited by 325
Acetaminophen-related Hepatotoxicity
Bunchorntavakul, C., & Reddy, K. R. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.005 · Cited by 322
“5) with undetectable serum APAP concentration.(1,69,103,116)”
BackgroundA 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993)
Makin, A. J., Wendon, J., & Williams, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90758-0 · Cited by 319
Self-citationA Review of Acetaminophen Poisoning
Hodgman, M. J., & Garrard, A. R. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.07.006 · Cited by 314
“This was demonstrated in several seminal papers in the early 1990s that showed improved transplant-free survival in patients with APAP-induced FHF.(51,52) The mechanism here is not the detoxification”
BackgroundInfluentialKarlson-Stiber, C., & Persson, H. (2003) · Toxicon · doi:10.1016/s0041-0101(03)00238-1 · Cited by 289
BEHR, J., MAIER, K., DEGENKOLB, B., KROMBACH, F., & VOGELMEIER, C. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9706065 · Cited by 283
Raghu, G., Berk, M., Campochiaro, P. A., Jaeschke, H., Marenzi, G., Richeldi, L., Wen, F.-Q., Nicoletti, F., & Calverley, P. M. A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666201230144109 · Cited by 280
Paracetamol (acetaminophen) poisoning
Thomas, S. H. L. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90023-7 · Cited by 263
Paracetamol (acetaminophen) poisoning
Vale, J. A., & Proudfoot, A. T. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91385-8 · Cited by 227
Zimmerman, H. J. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70097-0 · Cited by 186
Interventions for paracetamol (acetaminophen) overdose
Chiew, A. L., Gluud, C., Brok, J., & Buckley, N. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003328.pub3 · Cited by 170
Antioxidants in Critical Illness
Bulger, E. M. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.10.1201 · Cited by 158
Acetaminophen‐Related Acute Renal Failure without Fulminant Liver Failure
Eguia, L., & Materson, B. J. (1997) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03721.x · Cited by 126
Niu, H., Sanabria-Cabrera, J., Alvarez-Alvarez, I., Robles-Diaz, M., Stankevičiūtė, S., Aithal, G. P., Björnsson, E. S., Andrade, R. J., & Lucena, M. I. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105404 · Cited by 58
Acetylcysteine in paracetamol poisoning: a perspective of 45 years of use
Bateman, D. N., & Dear, J. W. (2019) · Toxicology Research · doi:10.1039/c9tx00002j · Cited by 53
Alcohol-acetaminophen syndrome: Even moderate social drinkers are at risk
Draganov, P., Durrence, H., Cox, C., & Reuben, A. (2000) · Postgraduate Medicine · doi:10.3810/pgm.2000.01.831 · Cited by 52
Morrison, E. E., Oatey, K., Gallagher, B., Grahamslaw, J., O'Brien, R., Black, P., Oosthuyzen, W., Lee, R. J., Weir, C. J., Henriksen, D., et al. (2019) · eBioMedicine · doi:10.1016/j.ebiom.2019.07.013 · Cited by 48
The current management of paracetamol overdosage
Makin, A., & Williams, R. (1994) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1994.tb09786.x · Cited by 38
Self-citationBateman, D. N., Dart, R. C., Dear, J. W., Prescott, L. F., & Rumack, B. H. (2023) · Clinical Toxicology · doi:10.1080/15563650.2023.2293452 · Cited by 25
Acheampong, P., & Thomas, S. H. L. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13028 · Cited by 25
Ding, G. K. A., & Buckley, N. A. (2008) · QJM · doi:10.1093/qjmed/hcn077 · Cited by 16
Fomepizole should not be used more liberally in paracetamol overdose
Dear, J. W. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15596 · Cited by 11
Metadata
- Authors
- Keays, R., Harrison, P. M., Wendon, J. A., Forbes, A., Gove, C., Alexander, G. J., & Williams, R.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1991-10-26
- Volume
- 303
- Issue
- 6809
- Pages
- 1026-1029
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2159790292
- Cited by
- 488
- References
- 17
- FWCI
- 10.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.